ArticleClinical cancer research : an official journal of the American Association for Cancer Research2021

First-in-Human Study of PF-06647020 (Cofetuzumab Pelidotin), an Antibody-Drug Conjugate Targeting Protein Tyrosine Kinase 7, in Advanced Solid Tumors.

Michael L Maitland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.